Company Focus

Otsuka

Latest Otsuka News

Otsuka submits NDA in Japan for bempedoic acid
Pharmaceutical
Japanese drugmaker Otsuka has announced the submission of a New Drug Application (NDA) to the Japanese Ministry of Health, Labor and Welfare (MHLW) for the manufacture and sale in Japan of bempedoic acid - trade name Nexletol in Japan - for the treatment of hypercholesterolemia and familial hypercholesterolemia.   27 November 2024


Latest News & Features of interest to Otsuka

Latest In Brief for Otsuka

Biotechnology
The Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) for the treatment of early Alzheimer’s disease (AD).   5 December 2024

Latest Relevant Ones To Watch News

Venture capital firm BC Partners has entered into an agreement under which the private equity business at Goldman Sachs Alternatives will acquire a majority stake in Netherlands-based Synthon, from funds advised by BC Partners.   17 December 2024

More in M&A >


Relevant Ones to Watch Companies

Reset all filters
Refine Search